Page 71 - EJMO-9-1
P. 71
Eurasian Journal of Medicine and
Oncology
Integrative prophetic medicine
139. Ernst E. Ethical problems arising in evidence based 2006;6(1):40.
complementary and alternative medicine. J Med Ethics.
2004;30(2):156-159. doi: 10.1186/1472-6882-6-40
149. Alsanad SM, Al-Khamees OA. Diabetic patients at risk from
doi: 10.1136/jme.2003.007021
herb-drug interactions. Adv Complement Amp Altern Med.
140. Alsanad SM, Williamson EM, Howard RL. Cancer patients 2023;7(5):733-741.
at risk of herb/food supplement-drug interactions:
A systematic review. Phytother Res. 2014;28(12):1749-1755. doi: 10.31031/acam.2023.07.000671
doi: 10.1002/ptr.5213 150. Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of
141. Williamson EM. Interactions between herbal and conventional complementary and alternative medicine (CAM) use by the
medicines. Expert Opin Drug Saf. 2005;4(2):355-378. general population: A systematic review and update. Int J
Clin Pract. 2012;66(10):924-939.
doi: 10.1517/14740338.4.2.355
doi: 10.1111/j.1742-1241.2012.02945.x
142. Alsanad SM, Howard RL, Williamson EM. An assessment
of the impact of herb-drug combinations used by cancer 151. Cangelosi G, Mancin S, Pantanetti P, et al. Lifestyle medicine
patients. BMC Complement Alternat Med. 2016;16(1):393. case manager nurses for type two diabetes patients: An
doi: 10.1186/s12906-016-1372-x overview of a job description framework-a narrative review.
Diabetology. 2024;5(4):375-388.
143. Ben-Arye E, Frenkel M, Klein A, Scharf M. Attitudes toward
integration of complementary and alternative medicine doi: 10.3390/diabetology5040029
in primary care: Perspectives of patients, physicians 152. Alsanad S, Chaudhary AA, Alhawas F, Alubied A,
and complementary practitioners. Patient Educ Couns.
2008;70(3):395-402. Alkhamees O. Saudi medical students’ attitudes toward
complementary & alternative medicine (CAM) and
doi: 10.1016/j.pec.2007.11.019 practicing integrative medicine (IM). Int J Pharm Sci Rev
144. Ernst E. Alternative Medicine: A Critical Assessment of 150 Res. 2017;45(1):48.
Modalities. Berlin: Springer; 2019.
153. Wiesener S, Falkenberg T, Hegyi G, Hök J, Roberti di Sarsina P,
145. Heinrich M, Williamson EM, Edwards SE, Rocha I. Fønnebø V. Legal status and regulation of complementary and
Phytopharmacy: An Evidence-Based Guide to Herbal Medicinal alternative medicine in Europe. Forsch Komplementarmedizin
Products. United States: Wiley & Sons, Incorporated; 2015. Res Complement Med. 2012;19(s2):29-36.
146. Evidence-Based Complementary and Alternative Medicine. doi: 10.1159/000343125
United Kingdom: Oxford University Press; 2004.
154. Fischer FH, Lewith G, Witt CM, et al. High prevalence
147. Richardson J. What patients expect from complementary
therapy: A qualitative study. Am J Public Health. but limited evidence in complementary and alternative
2004;94(6):1049-1053. medicine: Guidelines for future research. BMC Complement
Altern Med. 2014;14(1):46.
doi: 10.2105/ajph.94.6.1049
doi: 10.1186/1472-6882-14-46
148. Vickers KA, Jolly KB, Greenfield SM. Herbal medicine:
Women’s views, knowledge and interaction with doctors: 155. Rakel D, Minichiello V. Integrative Medicine. Netherlands:
A qualitative study. BMC Complement Alternat Med. Elsevier; 2022.
Volume 9 Issue 1 (2025) 63 doi: 10.36922/ejmo.6765

